Back to Search Start Over

The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels.

Authors :
Dong Y
Zhang G
Zhang B
Moir RD
Xia W
Marcantonio ER
Culley DJ
Crosby G
Tanzi RE
Xie Z
Source :
Archives of neurology [Arch Neurol] 2009 May; Vol. 66 (5), pp. 620-31.
Publication Year :
2009

Abstract

Objective: To assess the effects of sevoflurane, the most commonly used inhalation anesthetic, on apoptosis and beta-amyloid protein (Abeta) levels in vitro and in vivo. Subjects Naive mice, H4 human neuroglioma cells, and H4 human neuroglioma cells stably transfected to express full-length amyloid precursor protein.<br />Interventions: Human H4 neuroglioma cells stably transfected to express full-length amyloid precursor protein were exposed to 4.1% sevoflurane for 6 hours. Mice received 2.5% sevoflurane for 2 hours. Caspase-3 activation, apoptosis, and Abeta levels were assessed.<br />Results: Sevoflurane induced apoptosis and elevated levels of beta-site amyloid precursor protein-cleaving enzyme and Abeta in vitro and in vivo. The caspase inhibitor Z-VAD decreased the effects of sevoflurane on apoptosis and Abeta. Sevoflurane-induced caspase-3 activation was attenuated by the gamma-secretase inhibitor L-685,458 and was potentiated by Abeta. These results suggest that sevoflurane induces caspase activation which, in turn, enhances beta-site amyloid precursor protein-cleaving enzyme and Abeta levels. Increased Abeta levels then induce further rounds of apoptosis.<br />Conclusions: These results suggest that inhalational anesthetic sevoflurane may promote Alzheimer disease neuropathogenesis. If confirmed in human subjects, it may be prudent to caution against the use of sevoflurane as an anesthetic, especially in those suspected of possessing excessive levels of cerebral Abeta.

Details

Language :
English
ISSN :
1538-3687
Volume :
66
Issue :
5
Database :
MEDLINE
Journal :
Archives of neurology
Publication Type :
Academic Journal
Accession number :
19433662
Full Text :
https://doi.org/10.1001/archneurol.2009.48